{"id":348749,"date":"2025-08-25T14:52:29","date_gmt":"2025-08-25T14:52:29","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-soleno-therapeutics\/"},"modified":"2025-08-25T14:52:29","modified_gmt":"2025-08-25T14:52:29","slug":"how-to-buy-soleno-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/","title":{"rendered":"Soleno Therapeutics, Inc. (SLNO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Soleno Therapeutics, Inc. (SLNO) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-348749","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Soleno Therapeutics, Inc. (SLNO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Soleno Therapeutics, Inc. (SLNO) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Soleno Therapeutics, Inc. (SLNO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Soleno Therapeutics, Inc. (SLNO) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Soleno Therapeutics (SLNO) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 piyasa f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Soleno Therapeutics (SLNO) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 piyasa f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile \u00f6\u011frenin."},"intro":"Tarihi bir at\u0131l\u0131m ger\u00e7ekle\u015ftiren bir biyoteknoloji \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Soleno Therapeutics (SLNO), t\u0131bbi yenilik ve yat\u0131r\u0131m potansiyelinin heyecan verici kesi\u015fimini temsil ediyor. \u0130lk FDA onayl\u0131 tedavileri 2025'te piyasaya \u00e7\u0131karken, bu hisse hem \u00f6nemli bir y\u00fckseli\u015f potansiyeli hem de klasik biyoteknoloji volatilitesi sunuyor. \u015eimdi SLNO'yu cazip k\u0131lan unsurlar\u0131 ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Tarihi bir at\u0131l\u0131m ger\u00e7ekle\u015ftiren bir biyoteknoloji \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Soleno Therapeutics (SLNO), t\u0131bbi yenilik ve yat\u0131r\u0131m potansiyelinin heyecan verici kesi\u015fimini temsil ediyor. \u0130lk FDA onayl\u0131 tedavileri 2025'te piyasaya \u00e7\u0131karken, bu hisse hem \u00f6nemli bir y\u00fckseli\u015f potansiyeli hem de klasik biyoteknoloji volatilitesi sunuyor. \u015eimdi SLNO'yu cazip k\u0131lan unsurlar\u0131 ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 G\u00fcncel Piyasa Konumu ve Giri\u015f Stratejisi<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla, Soleno Therapeutics (SLNO) hisseleri <strong>68,57 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Bu fiyat, hisse senedinin ge\u00e7en ay 52 haftal\u0131k zirvesi olan 90,32 $'a ula\u015fmas\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda ilgin\u00e7 bir giri\u015f noktas\u0131 sunuyor. Temmuz zirvesinden yakla\u015f\u0131k %24'l\u00fck mevcut geri \u00e7ekilme, sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in stratejik bir al\u0131m f\u0131rsat\u0131 olabilir.<\/p> <p><strong>Takviminize Not Edin: 5 Kas\u0131m 2025<\/strong><br> Bu tarih SLNO yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in kesinlikle kritik. \u015eirket, piyasa kapan\u0131\u015f\u0131ndan sonra 2025 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak ve analistler ola\u011fan\u00fcst\u00fc bir \u015fey bekliyor - \u015firketin <strong>ilk karl\u0131 \u00e7eyre\u011fi<\/strong> ve konsens\u00fcs EPS tahmini 0,011 $ (<a href=\"https:\/\/www.moomoo.com\/stock\/SLNO-US\/earnings\">Moomoo Kazan\u00e7 Tahmini<\/a>).<\/p> <p>Tarihsel kazan\u00e7 kal\u0131plar\u0131, SLNO'nun beklentileri s\u00fcrekli a\u015ft\u0131\u011f\u0131n\u0131 g\u00f6steriyor. 6 A\u011fustos'ta a\u00e7\u0131klanan 2025 2. \u00e7eyrek raporu \u015fa\u015f\u0131rt\u0131c\u0131yd\u0131 - EPS -0,09 $ ile beklenen -0,53 $'\u0131 0,44 $ ile ezdi, gelir ise 32,66 milyon $ ile 3,91 milyon $ tahminini ezdi (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/SLNO\/earnings\/\">MarketBeat Kazan\u00e7 Verileri<\/a>).<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd0d Alt\u0131 Ayl\u0131k Fiyat Yolculu\u011fu: Ama\u00e7l\u0131 Bir Rollercoaster<\/h2> <p>SLNO'nun son alt\u0131 aydaki fiyat hareketi bir d\u00f6n\u00fc\u015f\u00fcm hikayesi anlat\u0131yor:<\/p> <ul> <li><strong>Mart 2025<\/strong>: FDA onay\u0131 heyecan\u0131yla hisse %46,35 ayl\u0131k patlama ya\u015fad\u0131, fiyat 43,00 $'dan 73,97 $'a y\u00fckseldi (<a href=\"https:\/\/stockscan.io\/stocks\/SLNO\/price-history\">StockScan Fiyat Ge\u00e7mi\u015fi<\/a>)<\/li> <li><strong>Nisan 2025<\/strong>: %4,77'lik devam eden momentum, ancak 19,55 $'l\u0131k y\u00fcksek volatilite ile<\/li> <li><strong>May\u0131s 2025<\/strong>: Yat\u0131r\u0131mc\u0131lar\u0131n k\u00e2r almas\u0131yla sa\u011fl\u0131kl\u0131 %-2,02 geri \u00e7ekilme<\/li> <li><strong>Haziran 2025<\/strong>: %14,22 g\u00fc\u00e7l\u00fc toparlanma, 72,96-86,79 $ aras\u0131nda yeni zirvelere do\u011fru<\/li> <li><strong>Temmuz 2025<\/strong>: Alt\u0131 ayl\u0131k zirve 90,32 $ ile %3,21'lik m\u00fctevaz\u0131 art\u0131\u015f<\/li> <li><strong>A\u011fustos 2025<\/strong>: Temmuz zirvesinden %24 geri \u00e7ekilme ile 68-70 $ civar\u0131nda konsolidasyon<\/li> <\/ul> <p>Bu model klasik biyoteknoloji davran\u0131\u015f\u0131n\u0131 g\u00f6steriyor - d\u00fczenleyici kataliz\u00f6rlerde patlay\u0131c\u0131 hareketler ve ard\u0131ndan konsolidasyon evreleri. Genel trend Mart diplerinden \u00f6nemli \u00f6l\u00e7\u00fcde y\u00fckseli\u015f y\u00f6n\u00fcnde.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 85-95 $ aral\u0131\u011f\u0131 - S\u00fcregelen ticari uygulama ve potansiyel k\u00e2rl\u0131l\u0131k \u00f6nceki zirvelere toparlanmay\u0131 desteklemeli<\/li> <li><strong>2026 Projeksiyonu<\/strong>: 100-120 $ - VYKAT XR'den tam y\u0131l gelir \u00fcretimi ve olas\u0131 \u00fcr\u00fcn hatt\u0131 geni\u015flemesi<\/li> <li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 150-180 $ - Pazar penetrasyonu derinle\u015fir ve potansiyel etiket geni\u015flemeleri b\u00fcy\u00fcmeyi tetikler<\/li> <li><strong>2030 Vizyonu<\/strong>: 200 $+ - \u00c7oklu gelir ak\u0131\u015flar\u0131na sahip yerle\u015fik nadir hastal\u0131k franchise'\u0131<\/li> <\/ul> <p><strong>Karar<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Mevcut geri \u00e7ekilme Kas\u0131m kazan\u00e7lar\u0131ndan \u00f6nce cazip bir giri\u015f noktas\u0131 sunuyor.<\/p> <h2>\u26a0\ufe0f Risk De\u011ferlendirmesi ve Pozitif Sinyaller<\/h2> <p><strong>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/strong><\/p> <ul> <li>150 g\u00fcnl\u00fck varsay\u0131lan volatilite %48,95 ile a\u015f\u0131r\u0131 volatilite (<a href=\"https:\/\/www.alphaquery.com\/stock\/SLNO\/volatility-option-statistics\/150-day\/iv-call\">AlphaQuery Volatilite Verileri<\/a>)<\/li> <li>Son Scorpion Capital raporu gibi k\u0131sa pozisyon sald\u0131r\u0131lar\u0131, %13 d\u00fc\u015f\u00fc\u015fe neden oldu (<a href=\"https:\/\/www.ainvest.com\/news\/short-selling-biotech-scorpion-capital-bearish-case-soleno-risks-high-stakes-drug-development-2508\/\">AInvest Raporu<\/a>)<\/li> <li>Tek \u00fcr\u00fcn VYKAT XR ba\u015far\u0131s\u0131na a\u011f\u0131r ba\u011f\u0131ml\u0131l\u0131k<\/li> <li>Biyoteknoloji d\u00fczenleyici belirsizli\u011fi ve klinik deneme riskleri<\/li> <\/ul> <p><strong>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/strong><\/p> <ul> <li>26 Mart 2025 FDA onay\u0131 al\u0131nd\u0131 - Prader-Willi Sendromu hipergafisi i\u00e7in ilk terapi<\/li> <li>\u0130lk \u00fc\u00e7 ayda 295 re\u00e7eteci taraf\u0131ndan 646 hasta ba\u015flang\u0131\u00e7 formu ile g\u00fc\u00e7l\u00fc ticari lansman<\/li> <li>32,66 milyon $ 2. \u00e7eyrek geliri, 3,91 milyon $ beklentisini b\u00fcy\u00fck \u00f6l\u00e7\u00fcde a\u015ft\u0131<\/li> <li>293,8 milyon $ nakit pozisyonu, \u00f6nemli operasyonel finansman sa\u011fl\u0131yor (<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/07\/10\/3113068\/0\/en\/Soleno-Therapeutics-Announces-Preliminary-Financial-and-Operational-Results-for-the-Second-Quarter-Ended-June-30-2025.html\">GlobeNewswire Finansal Veriler<\/a>)<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Volatiliteye dayanabilece\u011finiz bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n - biyoteknoloji g\u00fc\u00e7l\u00fc sinirler gerektirir<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Pozisyonunuzu bir kerede de\u011fil, kademeli olarak olu\u015fturmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>5 Kas\u0131m \u0130\u00e7in Uyar\u0131 Kurun<\/strong>: Kazan\u00e7lar i\u00e7in takviminize not edin - bu b\u00fcy\u00fck bir d\u00f6n\u00fcm noktas\u0131 olabilir<\/li> <li><strong>Uygun \u015eekilde \u00c7e\u015fitlendirin<\/strong>: Portf\u00f6y\u00fcn\u00fczde biyoteknoloji paylar\u0131n\u0131 makul seviyede tutun<\/li> <\/ol> <p>Mizahi bir yorum: \"SLNO ticareti, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir - inan\u0131lmaz heyecan verici potansiyel, ancak baz\u0131 dramatik ruh hali de\u011fi\u015fimleri ve karma\u015f\u0131k a\u00e7\u0131klamalara haz\u0131rl\u0131kl\u0131 olun!\"<\/p> <h2>\u2705 Soleno Therapeutics, Inc. (SLNO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table border=\"1\" cellspacing=\"0\" cellpadding=\"5\"> <thead> <tr> <th>Ad\u0131m<\/th> <th>\u0130\u015flem<\/th> <th>Neden \u00d6nemli<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Platformunuzu Se\u00e7in<\/td> <td>NASDAQ eri\u015fimi ve makul komisyon oranlar\u0131 sunan bir arac\u0131 kurum se\u00e7in<\/td> <\/tr> <tr> <td>2<\/td> <td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td> <td>Fon transferi yap\u0131n - potansiyel kay\u0131plara haz\u0131r oldu\u011funuz bir miktarla ba\u015flamay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/td> <\/tr> <tr> <td>3<\/td> <td>\"SLNO\" Aramas\u0131 Yap\u0131n<\/td> <td>Sadece \u015firket ad\u0131 de\u011fil, tam borsa sembol\u00fcn\u00fc kullan\u0131n<\/td> <\/tr> <tr> <td>4<\/td> <td>Emir T\u00fcr\u00fcn\u00fc Belirleyin<\/td> <td>Volatil hisselerde giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td> <\/tr> <tr> <td>5<\/td> <td>\u0130nceleyin ve Onaylay\u0131n<\/td> <td>Sat\u0131n alma \u00f6ncesi emir detaylar\u0131n\u0131 \u00e7ift kontrol edin<\/td> <\/tr> <tr> <td>6<\/td> <td>Pozisyonu \u0130zleyin<\/td> <td>Hem y\u00fckseli\u015f hedefleri hem de zarar durdurma seviyeleri i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td> <\/tr> <tr> <td>7<\/td> <td>Kazan\u00e7 Takvimini Takip Edin<\/td> <td>5 Kas\u0131m ve sonraki raporlama tarihlerini i\u015faretleyin<\/td> <\/tr> <tr> <td>8<\/td> <td>G\u00fcncel Kal\u0131n<\/td> <td>\u015eirket haberleri ve analist g\u00fcncellemelerini d\u00fczenli takip edin<\/td> <\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, Soleno Therapeutics hissesiyle strateji test etmek ad\u0131na \u00e7e\u015fitli avantajlar sunar:<\/p> <p><strong>Sadece 5 $ minimum depozito<\/strong>, k\u00fc\u00e7\u00fck pozisyonlarla biyoteknoloji yat\u0131r\u0131m dinamiklerini \u00f6\u011frenirken deneme yapman\u0131z\u0131 sa\u011flar. Platformun <strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong>, tek bir belge ile hemen i\u015flem yapmaya ba\u015flaman\u0131za olanak tan\u0131r. <strong>100'den fazla para \u00e7ekme y\u00f6ntemi<\/strong> aras\u0131nda \u00e7e\u015fitli kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k se\u00e7enekleri bulunur, b\u00f6ylece fonlar\u0131n\u0131zda esneklik sa\u011flars\u0131n\u0131z.<\/p> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, SLNO gibi volatil hisseleri takip etmeyi kolayla\u015ft\u0131r\u0131rken, d\u00fc\u015f\u00fck giri\u015f engeli \u00f6\u011frenme a\u015famas\u0131nda \u00f6nemli sermaye taahh\u00fcd\u00fc olmadan pratik deneyim kazanman\u0131z\u0131 sa\u011flar.<\/p> <h2>\ud83c\udf0d 2025'te Soleno Therapeutics: Nadir Hastal\u0131k \u00d6nc\u00fcs\u00fc<\/h2> <p>Soleno Therapeutics, 2025'te klinik a\u015famadan ticari ba\u015far\u0131ya ge\u00e7i\u015fte ola\u011fan\u00fcst\u00fc bir ba\u015far\u0131 elde etti - Prader-Willi Sendromu hipergafisi i\u00e7in FDA onayl\u0131 ilk terapi olan VYKAT XR ile. \u015eirketin nadir genetik hastal\u0131klara odaklanmas\u0131, s\u0131n\u0131rl\u0131 rekabet ve \u00f6nemli fiyatland\u0131rma g\u00fcc\u00fc olan \u00f6zel bir ni\u015fte konumlanmas\u0131n\u0131 sa\u011fl\u0131yor.<\/p> <p>Merkezi Redwood City, Kaliforniya'da bulunan Soleno, CEO Dr. Anish Bhatnagar liderli\u011finde 92 \u00f6zverili profesyonel istihdam ediyor. \u015eirketin bu y\u0131lki d\u00f6n\u00fc\u015f\u00fcm\u00fc, ara\u015ft\u0131rmadan onaya ve ticari uygulamaya kadar ba\u015far\u0131l\u0131 bir biyoteknoloji geli\u015fimi \u00f6rne\u011fi te\u015fkil ediyor.<\/p> <p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Ticari sat\u0131\u015flar\u0131n ilk \u00e7eyre\u011finde (2025 2. \u00e7eyrek), Soleno VYKAT XR'den 32,66 milyon $ gelir elde etti; bu, analist beklentisi olan 3,91 milyon $'\u0131n yakla\u015f\u0131k %735 \u00fczerinde. Bu \u015fa\u015f\u0131rt\u0131c\u0131 performans, Prader-Willi Sendromu'ndaki kar\u015f\u0131lanmam\u0131\u015f t\u0131bbi ihtiyac\u0131 ve \u015firketin etkili ticari lansman stratejisini g\u00f6steriyor.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 G\u00fcncel Piyasa Konumu ve Giri\u015f Stratejisi<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla, Soleno Therapeutics (SLNO) hisseleri <strong>68,57 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Bu fiyat, hisse senedinin ge\u00e7en ay 52 haftal\u0131k zirvesi olan 90,32 $&#8217;a ula\u015fmas\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda ilgin\u00e7 bir giri\u015f noktas\u0131 sunuyor. Temmuz zirvesinden yakla\u015f\u0131k %24&#8217;l\u00fck mevcut geri \u00e7ekilme, sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in stratejik bir al\u0131m f\u0131rsat\u0131 olabilir.<\/p>\n<p><strong>Takviminize Not Edin: 5 Kas\u0131m 2025<\/strong><br \/> Bu tarih SLNO yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in kesinlikle kritik. \u015eirket, piyasa kapan\u0131\u015f\u0131ndan sonra 2025 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak ve analistler ola\u011fan\u00fcst\u00fc bir \u015fey bekliyor &#8211; \u015firketin <strong>ilk karl\u0131 \u00e7eyre\u011fi<\/strong> ve konsens\u00fcs EPS tahmini 0,011 $ (<a href=\"https:\/\/www.moomoo.com\/stock\/SLNO-US\/earnings\">Moomoo Kazan\u00e7 Tahmini<\/a>).<\/p>\n<p>Tarihsel kazan\u00e7 kal\u0131plar\u0131, SLNO&#8217;nun beklentileri s\u00fcrekli a\u015ft\u0131\u011f\u0131n\u0131 g\u00f6steriyor. 6 A\u011fustos&#8217;ta a\u00e7\u0131klanan 2025 2. \u00e7eyrek raporu \u015fa\u015f\u0131rt\u0131c\u0131yd\u0131 &#8211; EPS -0,09 $ ile beklenen -0,53 $&#8217;\u0131 0,44 $ ile ezdi, gelir ise 32,66 milyon $ ile 3,91 milyon $ tahminini ezdi (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/SLNO\/earnings\/\">MarketBeat Kazan\u00e7 Verileri<\/a>).<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd0d Alt\u0131 Ayl\u0131k Fiyat Yolculu\u011fu: Ama\u00e7l\u0131 Bir Rollercoaster<\/h2>\n<p>SLNO&#8217;nun son alt\u0131 aydaki fiyat hareketi bir d\u00f6n\u00fc\u015f\u00fcm hikayesi anlat\u0131yor:<\/p>\n<ul>\n<li><strong>Mart 2025<\/strong>: FDA onay\u0131 heyecan\u0131yla hisse %46,35 ayl\u0131k patlama ya\u015fad\u0131, fiyat 43,00 $&#8217;dan 73,97 $&#8217;a y\u00fckseldi (<a href=\"https:\/\/stockscan.io\/stocks\/SLNO\/price-history\">StockScan Fiyat Ge\u00e7mi\u015fi<\/a>)<\/li>\n<li><strong>Nisan 2025<\/strong>: %4,77&#8217;lik devam eden momentum, ancak 19,55 $&#8217;l\u0131k y\u00fcksek volatilite ile<\/li>\n<li><strong>May\u0131s 2025<\/strong>: Yat\u0131r\u0131mc\u0131lar\u0131n k\u00e2r almas\u0131yla sa\u011fl\u0131kl\u0131 %-2,02 geri \u00e7ekilme<\/li>\n<li><strong>Haziran 2025<\/strong>: %14,22 g\u00fc\u00e7l\u00fc toparlanma, 72,96-86,79 $ aras\u0131nda yeni zirvelere do\u011fru<\/li>\n<li><strong>Temmuz 2025<\/strong>: Alt\u0131 ayl\u0131k zirve 90,32 $ ile %3,21&#8217;lik m\u00fctevaz\u0131 art\u0131\u015f<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: Temmuz zirvesinden %24 geri \u00e7ekilme ile 68-70 $ civar\u0131nda konsolidasyon<\/li>\n<\/ul>\n<p>Bu model klasik biyoteknoloji davran\u0131\u015f\u0131n\u0131 g\u00f6steriyor &#8211; d\u00fczenleyici kataliz\u00f6rlerde patlay\u0131c\u0131 hareketler ve ard\u0131ndan konsolidasyon evreleri. Genel trend Mart diplerinden \u00f6nemli \u00f6l\u00e7\u00fcde y\u00fckseli\u015f y\u00f6n\u00fcnde.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 85-95 $ aral\u0131\u011f\u0131 &#8211; S\u00fcregelen ticari uygulama ve potansiyel k\u00e2rl\u0131l\u0131k \u00f6nceki zirvelere toparlanmay\u0131 desteklemeli<\/li>\n<li><strong>2026 Projeksiyonu<\/strong>: 100-120 $ &#8211; VYKAT XR&#8217;den tam y\u0131l gelir \u00fcretimi ve olas\u0131 \u00fcr\u00fcn hatt\u0131 geni\u015flemesi<\/li>\n<li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 150-180 $ &#8211; Pazar penetrasyonu derinle\u015fir ve potansiyel etiket geni\u015flemeleri b\u00fcy\u00fcmeyi tetikler<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 200 $+ &#8211; \u00c7oklu gelir ak\u0131\u015flar\u0131na sahip yerle\u015fik nadir hastal\u0131k franchise&#8217;\u0131<\/li>\n<\/ul>\n<p><strong>Karar<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Mevcut geri \u00e7ekilme Kas\u0131m kazan\u00e7lar\u0131ndan \u00f6nce cazip bir giri\u015f noktas\u0131 sunuyor.<\/p>\n<h2>\u26a0\ufe0f Risk De\u011ferlendirmesi ve Pozitif Sinyaller<\/h2>\n<p><strong>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/strong><\/p>\n<ul>\n<li>150 g\u00fcnl\u00fck varsay\u0131lan volatilite %48,95 ile a\u015f\u0131r\u0131 volatilite (<a href=\"https:\/\/www.alphaquery.com\/stock\/SLNO\/volatility-option-statistics\/150-day\/iv-call\">AlphaQuery Volatilite Verileri<\/a>)<\/li>\n<li>Son Scorpion Capital raporu gibi k\u0131sa pozisyon sald\u0131r\u0131lar\u0131, %13 d\u00fc\u015f\u00fc\u015fe neden oldu (<a href=\"https:\/\/www.ainvest.com\/news\/short-selling-biotech-scorpion-capital-bearish-case-soleno-risks-high-stakes-drug-development-2508\/\">AInvest Raporu<\/a>)<\/li>\n<li>Tek \u00fcr\u00fcn VYKAT XR ba\u015far\u0131s\u0131na a\u011f\u0131r ba\u011f\u0131ml\u0131l\u0131k<\/li>\n<li>Biyoteknoloji d\u00fczenleyici belirsizli\u011fi ve klinik deneme riskleri<\/li>\n<\/ul>\n<p><strong>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/strong><\/p>\n<ul>\n<li>26 Mart 2025 FDA onay\u0131 al\u0131nd\u0131 &#8211; Prader-Willi Sendromu hipergafisi i\u00e7in ilk terapi<\/li>\n<li>\u0130lk \u00fc\u00e7 ayda 295 re\u00e7eteci taraf\u0131ndan 646 hasta ba\u015flang\u0131\u00e7 formu ile g\u00fc\u00e7l\u00fc ticari lansman<\/li>\n<li>32,66 milyon $ 2. \u00e7eyrek geliri, 3,91 milyon $ beklentisini b\u00fcy\u00fck \u00f6l\u00e7\u00fcde a\u015ft\u0131<\/li>\n<li>293,8 milyon $ nakit pozisyonu, \u00f6nemli operasyonel finansman sa\u011fl\u0131yor (<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/07\/10\/3113068\/0\/en\/Soleno-Therapeutics-Announces-Preliminary-Financial-and-Operational-Results-for-the-Second-Quarter-Ended-June-30-2025.html\">GlobeNewswire Finansal Veriler<\/a>)<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Volatiliteye dayanabilece\u011finiz bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n &#8211; biyoteknoloji g\u00fc\u00e7l\u00fc sinirler gerektirir<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Pozisyonunuzu bir kerede de\u011fil, kademeli olarak olu\u015fturmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>5 Kas\u0131m \u0130\u00e7in Uyar\u0131 Kurun<\/strong>: Kazan\u00e7lar i\u00e7in takviminize not edin &#8211; bu b\u00fcy\u00fck bir d\u00f6n\u00fcm noktas\u0131 olabilir<\/li>\n<li><strong>Uygun \u015eekilde \u00c7e\u015fitlendirin<\/strong>: Portf\u00f6y\u00fcn\u00fczde biyoteknoloji paylar\u0131n\u0131 makul seviyede tutun<\/li>\n<\/ol>\n<p>Mizahi bir yorum: &#8220;SLNO ticareti, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir &#8211; inan\u0131lmaz heyecan verici potansiyel, ancak baz\u0131 dramatik ruh hali de\u011fi\u015fimleri ve karma\u015f\u0131k a\u00e7\u0131klamalara haz\u0131rl\u0131kl\u0131 olun!&#8221;<\/p>\n<h2>\u2705 Soleno Therapeutics, Inc. (SLNO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"5\">\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Platformunuzu Se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve makul komisyon oranlar\u0131 sunan bir arac\u0131 kurum se\u00e7in<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td>\n<td>Fon transferi yap\u0131n &#8211; potansiyel kay\u0131plara haz\u0131r oldu\u011funuz bir miktarla ba\u015flamay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;SLNO&#8221; Aramas\u0131 Yap\u0131n<\/td>\n<td>Sadece \u015firket ad\u0131 de\u011fil, tam borsa sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Belirleyin<\/td>\n<td>Volatil hisselerde giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve Onaylay\u0131n<\/td>\n<td>Sat\u0131n alma \u00f6ncesi emir detaylar\u0131n\u0131 \u00e7ift kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonu \u0130zleyin<\/td>\n<td>Hem y\u00fckseli\u015f hedefleri hem de zarar durdurma seviyeleri i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Kazan\u00e7 Takvimini Takip Edin<\/td>\n<td>5 Kas\u0131m ve sonraki raporlama tarihlerini i\u015faretleyin<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>G\u00fcncel Kal\u0131n<\/td>\n<td>\u015eirket haberleri ve analist g\u00fcncellemelerini d\u00fczenli takip edin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, Soleno Therapeutics hissesiyle strateji test etmek ad\u0131na \u00e7e\u015fitli avantajlar sunar:<\/p>\n<p><strong>Sadece 5 $ minimum depozito<\/strong>, k\u00fc\u00e7\u00fck pozisyonlarla biyoteknoloji yat\u0131r\u0131m dinamiklerini \u00f6\u011frenirken deneme yapman\u0131z\u0131 sa\u011flar. Platformun <strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong>, tek bir belge ile hemen i\u015flem yapmaya ba\u015flaman\u0131za olanak tan\u0131r. <strong>100&#8217;den fazla para \u00e7ekme y\u00f6ntemi<\/strong> aras\u0131nda \u00e7e\u015fitli kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k se\u00e7enekleri bulunur, b\u00f6ylece fonlar\u0131n\u0131zda esneklik sa\u011flars\u0131n\u0131z.<\/p>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, SLNO gibi volatil hisseleri takip etmeyi kolayla\u015ft\u0131r\u0131rken, d\u00fc\u015f\u00fck giri\u015f engeli \u00f6\u011frenme a\u015famas\u0131nda \u00f6nemli sermaye taahh\u00fcd\u00fc olmadan pratik deneyim kazanman\u0131z\u0131 sa\u011flar.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Soleno Therapeutics: Nadir Hastal\u0131k \u00d6nc\u00fcs\u00fc<\/h2>\n<p>Soleno Therapeutics, 2025&#8217;te klinik a\u015famadan ticari ba\u015far\u0131ya ge\u00e7i\u015fte ola\u011fan\u00fcst\u00fc bir ba\u015far\u0131 elde etti &#8211; Prader-Willi Sendromu hipergafisi i\u00e7in FDA onayl\u0131 ilk terapi olan VYKAT XR ile. \u015eirketin nadir genetik hastal\u0131klara odaklanmas\u0131, s\u0131n\u0131rl\u0131 rekabet ve \u00f6nemli fiyatland\u0131rma g\u00fcc\u00fc olan \u00f6zel bir ni\u015fte konumlanmas\u0131n\u0131 sa\u011fl\u0131yor.<\/p>\n<p>Merkezi Redwood City, Kaliforniya&#8217;da bulunan Soleno, CEO Dr. Anish Bhatnagar liderli\u011finde 92 \u00f6zverili profesyonel istihdam ediyor. \u015eirketin bu y\u0131lki d\u00f6n\u00fc\u015f\u00fcm\u00fc, ara\u015ft\u0131rmadan onaya ve ticari uygulamaya kadar ba\u015far\u0131l\u0131 bir biyoteknoloji geli\u015fimi \u00f6rne\u011fi te\u015fkil ediyor.<\/p>\n<p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Ticari sat\u0131\u015flar\u0131n ilk \u00e7eyre\u011finde (2025 2. \u00e7eyrek), Soleno VYKAT XR&#8217;den 32,66 milyon $ gelir elde etti; bu, analist beklentisi olan 3,91 milyon $&#8217;\u0131n yakla\u015f\u0131k %735 \u00fczerinde. Bu \u015fa\u015f\u0131rt\u0131c\u0131 performans, Prader-Willi Sendromu&#8217;ndaki kar\u015f\u0131lanmam\u0131\u015f t\u0131bbi ihtiyac\u0131 ve \u015firketin etkili ticari lansman stratejisini g\u00f6steriyor.<\/p>\n"},"faq":[{"question":"Soleno Therapeutics (SLNO) hisseleri nereden al\u0131nabilir?","answer":"SLNO hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online yat\u0131r\u0131m platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"SLNO hisseleri i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 se\u00e7ti\u011finiz platforma ba\u011fl\u0131d\u0131r. \u00d6rne\u011fin, Pocket Option platformunda sadece 5 $ ile yat\u0131r\u0131m yapmaya ba\u015flayabilirsiniz."},{"question":"SLNO hisselerinin riskleri nelerdir?","answer":"SLNO hisseleri y\u00fcksek volatiliteye sahiptir ve tek bir \u00fcr\u00fcn olan VYKAT XR'nin ba\u015far\u0131s\u0131na ba\u011f\u0131ml\u0131d\u0131r. Ayr\u0131ca biyoteknoloji sekt\u00f6r\u00fcndeki d\u00fczenleyici ve klinik riskler de mevcuttur."},{"question":"SLNO hisseleri i\u00e7in 2025 sonras\u0131 fiyat beklentisi nedir?","answer":"2025 sonunda 85-95 $ aral\u0131\u011f\u0131nda, 2026'da 100-120 $, 2028'de 150-180 $ ve 2030'da 200 $ \u00fczeri fiyatlar \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Yeni ba\u015flayan biri SLNO hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131n, dolar maliyet ortalamas\u0131 yaparak pozisyonunuzu kademeli olu\u015fturun, \u00f6nemli kazan\u00e7 tarihlerini takip edin ve portf\u00f6y\u00fcn\u00fcz\u00fc uygun \u015fekilde \u00e7e\u015fitlendirin."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Soleno Therapeutics (SLNO) hisseleri nereden al\u0131nabilir?","answer":"SLNO hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online yat\u0131r\u0131m platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"SLNO hisseleri i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 se\u00e7ti\u011finiz platforma ba\u011fl\u0131d\u0131r. \u00d6rne\u011fin, Pocket Option platformunda sadece 5 $ ile yat\u0131r\u0131m yapmaya ba\u015flayabilirsiniz."},{"question":"SLNO hisselerinin riskleri nelerdir?","answer":"SLNO hisseleri y\u00fcksek volatiliteye sahiptir ve tek bir \u00fcr\u00fcn olan VYKAT XR'nin ba\u015far\u0131s\u0131na ba\u011f\u0131ml\u0131d\u0131r. Ayr\u0131ca biyoteknoloji sekt\u00f6r\u00fcndeki d\u00fczenleyici ve klinik riskler de mevcuttur."},{"question":"SLNO hisseleri i\u00e7in 2025 sonras\u0131 fiyat beklentisi nedir?","answer":"2025 sonunda 85-95 $ aral\u0131\u011f\u0131nda, 2026'da 100-120 $, 2028'de 150-180 $ ve 2030'da 200 $ \u00fczeri fiyatlar \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Yeni ba\u015flayan biri SLNO hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131n, dolar maliyet ortalamas\u0131 yaparak pozisyonunuzu kademeli olu\u015fturun, \u00f6nemli kazan\u00e7 tarihlerini takip edin ve portf\u00f6y\u00fcn\u00fcz\u00fc uygun \u015fekilde \u00e7e\u015fitlendirin."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Soleno Therapeutics, Inc. (SLNO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Soleno Therapeutics, Inc. (SLNO) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Soleno Therapeutics, Inc. (SLNO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Soleno Therapeutics, Inc. (SLNO) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T14:52:29+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Soleno Therapeutics, Inc. (SLNO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Soleno Therapeutics, Inc. (SLNO) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T14:52:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/\",\"name\":\"Soleno Therapeutics, Inc. (SLNO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Soleno Therapeutics, Inc. (SLNO) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-08-25T14:52:29+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Soleno Therapeutics, Inc. (SLNO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Soleno Therapeutics, Inc. (SLNO) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Soleno Therapeutics, Inc. (SLNO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Soleno Therapeutics, Inc. (SLNO) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/","og_locale":"tr_TR","og_type":"article","og_title":"Soleno Therapeutics, Inc. (SLNO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Soleno Therapeutics, Inc. (SLNO) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T14:52:29+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Soleno Therapeutics, Inc. (SLNO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Soleno Therapeutics, Inc. (SLNO) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T14:52:29+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/","name":"Soleno Therapeutics, Inc. (SLNO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Soleno Therapeutics, Inc. (SLNO) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-08-25T14:52:29+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-soleno-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Soleno Therapeutics, Inc. (SLNO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Soleno Therapeutics, Inc. (SLNO) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":348747,"slug":"how-to-buy-soleno-therapeutics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Soleno Therapeutics, Inc. (SLNO) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Soleno Therapeutics, Inc. (SLNO)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-soleno-therapeutics\/"},"pt_AA":{"locale":"pt_AA","id":348752,"slug":"how-to-buy-soleno-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Soleno Therapeutics, Inc. (SLNO) - Investimento em a\u00e7\u00f5es da Soleno Therapeutics, Inc. (SLNO)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-soleno-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/348749","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=348749"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/348749\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=348749"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=348749"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=348749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}